Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea · Delayed Price · Currency is KRW 7,860.00
-210.00 (-2.60%)
Last updated: Jun 30, 2026, 2:08 PM KST
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 168.25 billion as of June 30, 2026. Its market cap has decreased by -43.07% in one year.
Market Cap
168.25B
Enterprise Value
305.59B
Revenue
605.66B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,860.00
Market Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 168.25B, an increase of 831.63%. That is a compound annual growth rate of 9.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 168.25B | -34.31% |
| Dec 30, 2025 | 256.13B | -16.14% |
| Dec 30, 2024 | 305.43B | -7.98% |
| Dec 28, 2023 | 331.93B | -15.58% |
| Dec 29, 2022 | 393.20B | 14.64% |
| Dec 30, 2021 | 343.00B | -9.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suheung | 180.41B |
| REYON Pharmaceutical | 179.56B |
| Chong Kun Dang Holdings | 174.71B |
| Whan In Pharm | 170.61B |
| JW Lifescience | 170.02B |
| Hyundai Pharmaceutical | 167.45B |
| BNC KOREA | 165.86B |
| HLB Pharmaceutical | 157.41B |